The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation

Maurizio Margaglione, Giovanna D'Andrea, Marina D'Addedda, Nicola Giuliani, Giuseppe Cappucci, Luigi Iannaccone, Gennaro Vecchione, Elvira Grandone, Vincenzo Brancaccio, Giovanni Di Minno

Research output: Contribution to journalArticle

Abstract

A polymorphism, C→T677, in the methylenetetrahydrofolate reductase (MTHFR) gene has been identified as a cause of mild hyperhomocysteinemia, a risk factor for venous thrombosis. We have investigated the frequency of the TT genotype in 277 consecutive patients with confirmed deep venous thrombosis and 431 healthy subjects. The TT MTHFR genotype was more frequent in patients than in controls (25.6% vs. 18.1%; p = 0.016). The risk of thrombosis among carriers of this genotype was significantly increased [odds ratio: 1.6 (95% CI: 1.1-2.3)]. The estimated risk associated with the TT genotype was 2.0 (95% CI: 1.3-3.1) in subjects with (n = 122), and 1.3 (95% CI: 0.8-2.0) in those without (n = 155) predisposing (hereditary, acquired or circumstantial) risk factors for venous thrombosis. Factor V Leiden and prothrombin G→A20210 are known risk factors for venous thrombosis. After stratification for FV Leiden and prothrombin A20210 mutations, a significant association was also observed. After adjustment for sex, FV Leiden and prothrombin A20210 mutation, the estimated risk of venous thrombosis among carriers of the TT MTHFR genotype was 1.7 (95% CI: 1.2-2.6). The TT MTHFR genotype is independently associated with venous thrombosis, mainly among individuals with a high risk profile.

Original languageEnglish
Pages (from-to)907-911
Number of pages5
JournalThrombosis and Haemostasis
Volume79
Issue number5
Publication statusPublished - May 1998

Fingerprint

Methylenetetrahydrofolate Reductase (NADPH2)
Prothrombin
Venous Thrombosis
Genotype
Mutation
Hyperhomocysteinemia
factor V Leiden
Healthy Volunteers
Thrombosis
Odds Ratio
Genes

ASJC Scopus subject areas

  • Hematology

Cite this

The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. / Margaglione, Maurizio; D'Andrea, Giovanna; D'Addedda, Marina; Giuliani, Nicola; Cappucci, Giuseppe; Iannaccone, Luigi; Vecchione, Gennaro; Grandone, Elvira; Brancaccio, Vincenzo; Di Minno, Giovanni.

In: Thrombosis and Haemostasis, Vol. 79, No. 5, 05.1998, p. 907-911.

Research output: Contribution to journalArticle

Margaglione, Maurizio ; D'Andrea, Giovanna ; D'Addedda, Marina ; Giuliani, Nicola ; Cappucci, Giuseppe ; Iannaccone, Luigi ; Vecchione, Gennaro ; Grandone, Elvira ; Brancaccio, Vincenzo ; Di Minno, Giovanni. / The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. In: Thrombosis and Haemostasis. 1998 ; Vol. 79, No. 5. pp. 907-911.
@article{09a6cf26b7f840009394ae6b43008a4a,
title = "The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation",
abstract = "A polymorphism, C→T677, in the methylenetetrahydrofolate reductase (MTHFR) gene has been identified as a cause of mild hyperhomocysteinemia, a risk factor for venous thrombosis. We have investigated the frequency of the TT genotype in 277 consecutive patients with confirmed deep venous thrombosis and 431 healthy subjects. The TT MTHFR genotype was more frequent in patients than in controls (25.6{\%} vs. 18.1{\%}; p = 0.016). The risk of thrombosis among carriers of this genotype was significantly increased [odds ratio: 1.6 (95{\%} CI: 1.1-2.3)]. The estimated risk associated with the TT genotype was 2.0 (95{\%} CI: 1.3-3.1) in subjects with (n = 122), and 1.3 (95{\%} CI: 0.8-2.0) in those without (n = 155) predisposing (hereditary, acquired or circumstantial) risk factors for venous thrombosis. Factor V Leiden and prothrombin G→A20210 are known risk factors for venous thrombosis. After stratification for FV Leiden and prothrombin A20210 mutations, a significant association was also observed. After adjustment for sex, FV Leiden and prothrombin A20210 mutation, the estimated risk of venous thrombosis among carriers of the TT MTHFR genotype was 1.7 (95{\%} CI: 1.2-2.6). The TT MTHFR genotype is independently associated with venous thrombosis, mainly among individuals with a high risk profile.",
author = "Maurizio Margaglione and Giovanna D'Andrea and Marina D'Addedda and Nicola Giuliani and Giuseppe Cappucci and Luigi Iannaccone and Gennaro Vecchione and Elvira Grandone and Vincenzo Brancaccio and {Di Minno}, Giovanni",
year = "1998",
month = "5",
language = "English",
volume = "79",
pages = "907--911",
journal = "Thrombosis and Haemostasis",
issn = "0340-6245",
publisher = "Schattauer GmbH",
number = "5",

}

TY - JOUR

T1 - The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation

AU - Margaglione, Maurizio

AU - D'Andrea, Giovanna

AU - D'Addedda, Marina

AU - Giuliani, Nicola

AU - Cappucci, Giuseppe

AU - Iannaccone, Luigi

AU - Vecchione, Gennaro

AU - Grandone, Elvira

AU - Brancaccio, Vincenzo

AU - Di Minno, Giovanni

PY - 1998/5

Y1 - 1998/5

N2 - A polymorphism, C→T677, in the methylenetetrahydrofolate reductase (MTHFR) gene has been identified as a cause of mild hyperhomocysteinemia, a risk factor for venous thrombosis. We have investigated the frequency of the TT genotype in 277 consecutive patients with confirmed deep venous thrombosis and 431 healthy subjects. The TT MTHFR genotype was more frequent in patients than in controls (25.6% vs. 18.1%; p = 0.016). The risk of thrombosis among carriers of this genotype was significantly increased [odds ratio: 1.6 (95% CI: 1.1-2.3)]. The estimated risk associated with the TT genotype was 2.0 (95% CI: 1.3-3.1) in subjects with (n = 122), and 1.3 (95% CI: 0.8-2.0) in those without (n = 155) predisposing (hereditary, acquired or circumstantial) risk factors for venous thrombosis. Factor V Leiden and prothrombin G→A20210 are known risk factors for venous thrombosis. After stratification for FV Leiden and prothrombin A20210 mutations, a significant association was also observed. After adjustment for sex, FV Leiden and prothrombin A20210 mutation, the estimated risk of venous thrombosis among carriers of the TT MTHFR genotype was 1.7 (95% CI: 1.2-2.6). The TT MTHFR genotype is independently associated with venous thrombosis, mainly among individuals with a high risk profile.

AB - A polymorphism, C→T677, in the methylenetetrahydrofolate reductase (MTHFR) gene has been identified as a cause of mild hyperhomocysteinemia, a risk factor for venous thrombosis. We have investigated the frequency of the TT genotype in 277 consecutive patients with confirmed deep venous thrombosis and 431 healthy subjects. The TT MTHFR genotype was more frequent in patients than in controls (25.6% vs. 18.1%; p = 0.016). The risk of thrombosis among carriers of this genotype was significantly increased [odds ratio: 1.6 (95% CI: 1.1-2.3)]. The estimated risk associated with the TT genotype was 2.0 (95% CI: 1.3-3.1) in subjects with (n = 122), and 1.3 (95% CI: 0.8-2.0) in those without (n = 155) predisposing (hereditary, acquired or circumstantial) risk factors for venous thrombosis. Factor V Leiden and prothrombin G→A20210 are known risk factors for venous thrombosis. After stratification for FV Leiden and prothrombin A20210 mutations, a significant association was also observed. After adjustment for sex, FV Leiden and prothrombin A20210 mutation, the estimated risk of venous thrombosis among carriers of the TT MTHFR genotype was 1.7 (95% CI: 1.2-2.6). The TT MTHFR genotype is independently associated with venous thrombosis, mainly among individuals with a high risk profile.

UR - http://www.scopus.com/inward/record.url?scp=18344398980&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18344398980&partnerID=8YFLogxK

M3 - Article

C2 - 9609218

AN - SCOPUS:18344398980

VL - 79

SP - 907

EP - 911

JO - Thrombosis and Haemostasis

JF - Thrombosis and Haemostasis

SN - 0340-6245

IS - 5

ER -